Adage Capital Partners Gp, L.L.C. Geron Corp Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Geron Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 21,800,000 shares of GERN stock, worth $55.8 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
21,800,000
Previous 28,875,000
24.5%
Holding current value
$55.8 Million
Previous $131 Million
41.13%
% of portfolio
0.14%
Previous 0.24%
Shares
5 transactions
Others Institutions Holding GERN
# of Institutions
304Shares Held
460MCall Options Held
1.44MPut Options Held
687K-
Black Rock Inc. New York, NY46.6MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$85.9 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$76.8 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$69.7 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$69.5 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $967M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...